China Hunan Yunbang Biotech Inc. company news

November 1, 2022 | Robust levels of large extracellular vesicles (LEVs) were found “hiding in plain sight” in the blood of early-stage breast cancer patients in a recent study led by a team of scientists at the University of Southern California (USC). The LEVs are roughly the size of a cell and ... Read More

October 27, 2022 | Clinical whole exome sequencing services identify possible disease-causing genetic changes; a composite biomarker system uses multiple clinically relevant patient features to reflect the heterogeneity of graft failure; a regulatory science tool improves the review processes for ... Read More

Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). One key difference is that long COVID has ... Read More

Meeting the needs of patients, providers, and payers will be key to overcoming the limitations of current point-of-care (POC) testing methods, according to keynote speaker Timothy Still, CEO of Sense Biodetection, on the opening day of the Next Generation Dx Summit in Washington, D.C. Many of the ... Read More

Secondary bacterial and fungal infections have threatened hospitalized patients for decades and become more urgent as pathogens develop resistance to common antibiotics. Recently, the Centers for Disease Control and Prevention confirmed what many frontline workers and epidemiologists already ... Read More

Attention COVID-19 research community: the Mayo Clinic has made a discovery that could help explain why some people who get infected with the SARS-CoV-2 virus suffer badly while others feel only mildly ill. The hypothesis to be tested is whether an increase in protein expression controlled by ACE2 ... Read More